If you have been prescribed lisdexamfetamine dimesylate capsules to treat ADHD, you should know the FDA has recalled several lots of this medication.

ADHD medication being recalled nationwide after failing effectiveness tests - Lisdexamfetamine dimesylate is the generic form ...

Sun Pharmaceutical has announced a voluntary recall of its popular Attention-Deficit/Hyperactivity Disorder drug.The ...

According to an enforcement report from the Food and Drug Administration (FDA), Sun Pharmaceutical Industries Inc. initiated ...

The FDA's recall pertains to several lots of lisdexamfetamine dimesylate capsules that failed to meet essential dissolution tests. Dissolution is a crucial process in pharmacology that determines how ...

A popular ADHD medication is being recalled nationwide because its users won’t be able to get the full effect.

According to the recall, the Food and Drug Administration said the affected lots of the medication did not dissolve as ...

ST. JOSPEH, Mo. (KQTV) -- A heavily used Attention Deficit Hyperactivity Disorder (ADHD) medication is being recalled because ...

In a significant move to mitigate the ongoing shortage of ADHD medications in the U.S., the Drug Enforcement Administration (DEA) has authorized a substantial increase in the production limits for ...

Takeda Pharmaceutical Co Ltd (NYSE: TAK), a manufacturer of Vyvanse, has confirmed that the drug is experiencing low inventory due to manufacturing complications. A spokesperson from the company ...

NEW YORK (Reuters Health) - The stimulant drug Vyvanse improves attention deficit hyperactivity disorder (ADHD) in adolescents beginning as early as the first week of treatment, according to a new ...